These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2902503)
1. The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Cohen RM; Semple WE; Gross M; Nordahl TE; Holcomb HH; Dowling MS; Pickar D Life Sci; 1988; 43(14):1141-50. PubMed ID: 2902503 [TBL] [Abstract][Full Text] [Related]
2. Dysfunction in a prefrontal substrate of sustained attention in schizophrenia. Cohen RM; Semple WE; Gross M; Nordahl TE; DeLisi LE; Holcomb HH; King AC; Morihisa JM; Pickar D Life Sci; 1987 May; 40(20):2031-9. PubMed ID: 3494899 [TBL] [Abstract][Full Text] [Related]
3. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia. Cohen RM; Nordahl TE; Semple WE; Andreason P; Pickar D Neuropsychopharmacology; 1998 Jul; 19(1):36-47. PubMed ID: 9608575 [TBL] [Abstract][Full Text] [Related]
4. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task. Cohen RM; Nordahl TE; Semple WE; Andreason P; Litman RE; Pickar D Arch Gen Psychiatry; 1997 May; 54(5):481-6. PubMed ID: 9152102 [TBL] [Abstract][Full Text] [Related]
6. Toward a brain map of auditory hallucinations. Cleghorn JM; Franco S; Szechtman B; Kaplan RD; Szechtman H; Brown GM; Nahmias C; Garnett ES Am J Psychiatry; 1992 Aug; 149(8):1062-9. PubMed ID: 1353314 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Buchsbaum MS; Wu JC; DeLisi LE; Holcomb HH; Hazlett E; Cooper-Langston K; Kessler R Biol Psychiatry; 1987 Apr; 22(4):479-94. PubMed ID: 2882788 [TBL] [Abstract][Full Text] [Related]
8. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836 [TBL] [Abstract][Full Text] [Related]
9. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Lahti AC; Holcomb HH; Medoff DR; Weiler MA; Tamminga CA; Carpenter WT Am J Psychiatry; 2001 Nov; 158(11):1797-808. PubMed ID: 11691685 [TBL] [Abstract][Full Text] [Related]
10. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194 [TBL] [Abstract][Full Text] [Related]
11. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration. Volkow ND; Brodie JD; Wolf AP; Angrist B; Russell J; Cancro R J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1199-1202. PubMed ID: 3491182 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients. Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552 [TBL] [Abstract][Full Text] [Related]
13. From syndrome to illness: delineating the pathophysiology of schizophrenia with PET. Cohen RM; Semple WE; Gross M; Nordahl TE Schizophr Bull; 1988; 14(2):169-76. PubMed ID: 3059466 [TBL] [Abstract][Full Text] [Related]
14. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979 [TBL] [Abstract][Full Text] [Related]
15. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. Reynolds GP; Rossor MN; Iversen LL J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746 [TBL] [Abstract][Full Text] [Related]
16. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Cohen RM; Semple WE; Gross M; Nordahl TE; King AC; Pickar D; Post RM Neuropsychopharmacology; 1989 Dec; 2(4):241-54. PubMed ID: 2610821 [TBL] [Abstract][Full Text] [Related]
17. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Holcomb HH; Cascella NG; Thaker GK; Medoff DR; Dannals RF; Tamminga CA Am J Psychiatry; 1996 Jan; 153(1):41-9. PubMed ID: 8540590 [TBL] [Abstract][Full Text] [Related]
18. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379 [TBL] [Abstract][Full Text] [Related]
19. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Meisenzahl EM; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller HJ Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):522-31. PubMed ID: 17151834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]